NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PROJECT LYME, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $982K in total revenue in fiscal year 2023. Revenue surged 24% from the prior year, signaling strong growth momentum. The organization ran a surplus of $201K, a strong 20% operating margin.
PROJECT LYME'S MISSION IS TO ERADICATE THE EPIDEMIC OF LYME DISEASE AND OTHER TICK-BORNE ILLNESSES BY SPREADING AWARENESS, PROVIDING EDUCATIONAL RESOURCES, FUNDING PEER-REVIEWED RESEARCH, AND SUPPORTING ADVOCACY FOR SOLUTIONS TO END THE SUFFERING. SINCE 2016, PROJECT LYME HAS CHALLENGED MISINFORMATION ABOUT DIAGNOSIS AND TREATMENT, ADVOCATED FOR PATIENTS' RIGHTS, AND BUILT A COMMUNITY FOR LYME PATIENTS AS WELL AS THEIR LOVED ONES.
EDUCATION AND AWARENESS: EDUCATION, AWARENESS, AND ADVOCACY ARE PROJECT LYME'S THREE LARGEST INITIATIVES FROM AN EMPLOYMENT AND PUBLIC ENGAGEMENT STANDPOINT. THESE FUNDS ARE SPLIT BETWEEN FUNDING THE...
EDUCATION AND AWARENESS: EDUCATION, AWARENESS, AND ADVOCACY ARE PROJECT LYME'S THREE LARGEST INITIATIVES FROM AN EMPLOYMENT AND PUBLIC ENGAGEMENT STANDPOINT. THESE FUNDS ARE SPLIT BETWEEN FUNDING THE DISTRIBUTION OF DOCUMENTARY FILM THE QUIET EPIDEMIC, CREATING SOCIAL MEDIA AND WEBSITE CONTENT FOR @PROJECTLYME AND PROJECTLYME.ORG, CREATING AND DISTRIBUTING PUBLIC SERVICE ANNOUCEMENTS, AS WELL AS SPONSORSHIP ONLINE AND IN-PERSON EDUCATIONAL SEMINARS AND ADVOCACY EVENTS. WE DISTRIBUTED $47,500 TO THE QUIET EPIDEMIC, $14,824 TO GENERATION LYME, $5,000 TO ILADS AND OTHER MINOR GRANTS TO ORGANIZATIONS WORKING IN EDUCATION AND AWARENESS.
RESEARCH: PROJECT LYME DIRECTS FUNDS FOR RESEARCH THROUGH OUR PARTNER ORGANIZATION BAY AREA LYME FOUNDATION. THE MAIN FOCUS OF THIS PROGRAM IS TO INCREASE THE VIABILITY OF DIAGNOSTICS AVAILABLE TO...
RESEARCH: PROJECT LYME DIRECTS FUNDS FOR RESEARCH THROUGH OUR PARTNER ORGANIZATION BAY AREA LYME FOUNDATION. THE MAIN FOCUS OF THIS PROGRAM IS TO INCREASE THE VIABILITY OF DIAGNOSTICS AVAILABLE TO THE GENERAL PUBLIC AND THERAPEUTICS AVAILABLE FOR PATIENTS. WE DISTRIBUTED $222,000 TO BAY AREA LYME.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $982,451 | $790,982 | +0.2% |
| Expenses | $781,172 | $778,653 | +0.0% |
| Net Income | $201,279 | $12,329 | +15.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| NOAH JOHNSTON | EXECUTIVE DIRECTOR | 40 |
Officer
|
$120,000 | $0 | $120,000 |
| DAVID ROTH | EXECUTIVE COMMITTEE CHAIR | 2 |
Officer
Director
|
$0 | $0 | $0 |
| JENNIFER WEIS | BOARD CO-CHAIR | 5 |
Officer
Director
|
$0 | $0 | $0 |
| NAN KURZMAN | BOARD CO-CHAIR | 2 |
Officer
Director
|
$0 | $0 | $0 |
| SCOTT MORESCO | TREASURER | 5 |
Officer
Director
|
$0 | $0 | $0 |
| KIM DICKSTEIN | SECRETARY | 5 |
Officer
Director
|
$0 | $0 | $0 |
| MARK WEBER | BOARD MEMBER | 2 |
Director
|
$0 | $0 | $0 |
| MELISSA BELL | BOARD MEMBER | 10 |
Director
|
$0 | $0 | $0 |
| ISABEL ROSE | BOARD MEMBER | 5 |
Director
|
$0 | $0 | $0 |
| ALEXANDRA MORESCO | BOARD MEMBER | 10 |
Director
|
$0 | $0 | $0 |
| SUSAN GOLDENBERG | BOARD MEMBER | 5 |
Director
|
$0 | $0 | $0 |
| NINA LEVENE | BOARD MEMBER | 1 |
Director
|
$0 | $0 | $0 |
| STEVE ABRAMS | BOARD MEMBER | 2 |
Director
|
$0 | $0 | $0 |
| BOB FORSTER | BOARD MEMBER | 1 |
Director
|
$0 | $0 | $0 |
| PHYLLIS BEDFORD | BOARD MEMBER | 2 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $982,451 | $781,172 | $1,182,606 | $201,279 |
| 2022 | $790,982 | $778,653 | $981,327 | $12,329 |
| 2021 | $575,104 | $645,309 | $968,998 | $-70,205 |
| 2020 | $1,541,914 | $983,981 | $1,039,203 | $557,933 |
| 2019 | $310,458 | $441,002 | $482,270 | $-130,544 |
| 2018 | $767,403 | $370,284 | $518,679 | $397,119 |
Compare PROJECT LYME with other nonprofits in New York and across the country.